NO3030259T3 - - Google Patents

Info

Publication number
NO3030259T3
NO3030259T3 NO14772444A NO14772444A NO3030259T3 NO 3030259 T3 NO3030259 T3 NO 3030259T3 NO 14772444 A NO14772444 A NO 14772444A NO 14772444 A NO14772444 A NO 14772444A NO 3030259 T3 NO3030259 T3 NO 3030259T3
Authority
NO
Norway
Application number
NO14772444A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO3030259T3 publication Critical patent/NO3030259T3/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
NO14772444A 2013-08-06 2014-08-06 NO3030259T3 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201314052A GB201314052D0 (en) 2013-08-06 2013-08-06 Peptides
PCT/IB2014/063739 WO2015019302A2 (en) 2013-08-06 2014-08-06 Peptides

Publications (1)

Publication Number Publication Date
NO3030259T3 true NO3030259T3 (no) 2018-05-26

Family

ID=49224229

Family Applications (1)

Application Number Title Priority Date Filing Date
NO14772444A NO3030259T3 (no) 2013-08-06 2014-08-06

Country Status (32)

Country Link
US (2) US9938329B2 (no)
EP (1) EP3030259B1 (no)
JP (1) JP6476181B2 (no)
KR (1) KR102431507B1 (no)
CN (1) CN105636980B (no)
AU (1) AU2014304108B2 (no)
BR (1) BR112016002572A2 (no)
CA (1) CA2920321C (no)
CY (1) CY1120212T1 (no)
DK (1) DK3030259T3 (no)
ES (1) ES2664045T3 (no)
GB (1) GB201314052D0 (no)
HK (1) HK1219058A1 (no)
HR (1) HRP20180452T1 (no)
HU (1) HUE038569T2 (no)
IL (1) IL243892B (no)
LT (1) LT3030259T (no)
MX (1) MX369412B (no)
MY (1) MY177371A (no)
NO (1) NO3030259T3 (no)
NZ (1) NZ717350A (no)
PE (1) PE20160778A1 (no)
PH (1) PH12016500218A1 (no)
PL (1) PL3030259T3 (no)
PT (1) PT3030259T (no)
RS (1) RS57196B1 (no)
RU (1) RU2676149C2 (no)
SG (1) SG11201600895SA (no)
SI (1) SI3030259T1 (no)
UA (1) UA120746C2 (no)
WO (1) WO2015019302A2 (no)
ZA (1) ZA201600729B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201314052D0 (en) * 2013-08-06 2013-09-18 Apitope Int Nv Peptides
WO2016103213A1 (en) * 2014-12-24 2016-06-30 Apitope International Nv Composition
JP2020503353A (ja) * 2017-01-04 2020-01-30 アピトープ インターナショナル エヌブイ 寛容原性ペプチドを用いた治療方法
EP3369743A1 (en) * 2017-03-01 2018-09-05 advanceCOR GmbH Cyclic peptides for the treatment of graves' disease
EP3622962A1 (en) * 2018-09-14 2020-03-18 advanceCOR GmbH Short cyclic peptides for the treatment of graves' disease
GB201909774D0 (en) 2019-07-08 2019-08-21 Apitope Tech Bristol Limited Method

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68927461T2 (de) * 1989-12-14 1997-03-20 Brahms Diagnostica Gmbh Polypeptide mit Thyrotropinrezeptor-Aktivität, kodierende Nukleinsäuresequenzen für solche Rezeptoren und Verwendung dieser Polypeptide
HU229377B1 (hu) 2000-08-21 2013-11-28 Apitope Technology Bristol Ltd Tolerogén humán peptidek
GB0202399D0 (en) * 2002-02-01 2002-03-20 Univ Bristol Peptide
FR2842812A1 (fr) 2002-07-26 2004-01-30 Pf Medicament Procede de solubilisation de peptides hydrophobes et leur utilisation pour generer une reponse de type ctl antitumorale ou anti-infectueuse
JP2006188507A (ja) * 2004-12-10 2006-07-20 Tokyo Univ Of Agriculture & Technology 蛋白質の溶解度向上方法
US20080305098A1 (en) 2005-11-21 2008-12-11 Dr. Fenning Biomed Gmbh Recombinant Polypeptides and Methods for Detecting and/or Quantifying Autoantibodies Against Tsh Receptor
CL2007002926A1 (es) 2006-10-12 2008-05-16 Genentech Inc Anticuerpo antilinfotoxina alfa (lt-alfa); composicion con el anticuerpo; hibridoma pta-7538; acido nucleico codificante del anticuerpo; vector y celula huesped que comprenden el acido nucleico; metodo para inhibir la proliferacion celular activada p
GB0723712D0 (en) 2007-12-04 2008-01-16 Apitope Technology Bristol Ltd Peptides
GB0908515D0 (en) 2009-05-18 2009-06-24 Apitope Technology Bristol Ltd Peptide
GB201314052D0 (en) * 2013-08-06 2013-09-18 Apitope Int Nv Peptides

Also Published As

Publication number Publication date
JP2016527304A (ja) 2016-09-08
HUE038569T2 (hu) 2018-10-29
ES2664045T3 (es) 2018-04-18
AU2014304108B2 (en) 2018-03-08
US20180327463A1 (en) 2018-11-15
SI3030259T1 (en) 2018-07-31
AU2014304108A1 (en) 2016-02-25
US20160185833A1 (en) 2016-06-30
CY1120212T1 (el) 2018-12-12
CA2920321C (en) 2022-10-18
WO2015019302A3 (en) 2015-08-27
PT3030259T (pt) 2018-03-20
MY177371A (en) 2020-09-14
BR112016002572A2 (pt) 2017-09-12
RU2016107873A (ru) 2017-09-12
CA2920321A1 (en) 2015-02-12
PL3030259T3 (pl) 2018-07-31
CN105636980A (zh) 2016-06-01
IL243892B (en) 2019-11-28
GB201314052D0 (en) 2013-09-18
PH12016500218A1 (en) 2016-04-25
EP3030259A2 (en) 2016-06-15
KR20160036059A (ko) 2016-04-01
MX369412B (es) 2019-11-07
IL243892A0 (en) 2016-04-21
EP3030259B1 (en) 2017-12-27
KR102431507B1 (ko) 2022-08-10
PE20160778A1 (es) 2016-08-06
CN105636980B (zh) 2021-05-04
NZ717350A (en) 2019-03-29
US9938329B2 (en) 2018-04-10
HK1219058A1 (en) 2017-03-24
LT3030259T (lt) 2018-05-10
US10730919B2 (en) 2020-08-04
HRP20180452T1 (hr) 2018-06-01
RU2676149C2 (ru) 2018-12-26
DK3030259T3 (en) 2018-04-16
ZA201600729B (en) 2019-12-18
SG11201600895SA (en) 2016-03-30
UA120746C2 (uk) 2020-02-10
MX2016001744A (es) 2016-05-18
WO2015019302A2 (en) 2015-02-12
RS57196B1 (sr) 2018-07-31
JP6476181B2 (ja) 2019-02-27

Similar Documents

Publication Publication Date Title
AP2016009275A0 (no)
BR112016012378A2 (no)
BR112015007533A2 (no)
BR102016010778A2 (no)
BR112014017733A2 (no)
BR112014017739A2 (no)
BR112014018502A2 (no)
BR112014019326A2 (no)
BR112014018516A2 (no)
BR112014018480A2 (no)
BR112014017765A2 (no)
BR112014017855A2 (no)
BR112014017669A2 (no)
BR112014021878A2 (no)
BR112016004918A2 (no)
BR112014018468A2 (no)
BR112014018207A2 (no)
BR112014017901A2 (no)
BR112014019204A2 (no)
BR112015015948A2 (no)
BR112014017722A2 (no)
BR112015016283A2 (no)
BR112014018578A2 (no)
BR112014018483A2 (no)
BR112014017794A2 (no)